Hepion Pharmaceuticals, Inc. is a medical diagnostic company headquartered in Morristown, New Jersey. Previously focused on chronic liver disease drug therapy via its cyclophilin inhibitor rencofilstat, the company pivoted to diagnostics after halting its ASCEND-NASH clinical trial. It in-licensed diagnostic tests for celiac disease, respiratory multiplex (Covid/Influenza A/B/RSV), H. pylori, and hepatocellular carcinoma from New Day Diagnostics, and licensed liver disease diagnostic assets from Cirna Diagnostics.
Q2 FY2026 — expected 2026-09-10
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-12 | 2025-12-31 | 0001493152-26-009755 | EDGAR | 56K words |
| 2025-04-08 | 2024-12-31 | 0001641172-25-003250 | EDGAR | — |
| 2024-04-16 | 2023-12-31 | 0001583771-24-000003 | EDGAR | — |
| 2023-04-10 | 2022-12-31 | 0001583771-23-000003 | EDGAR | — |
| 2022-04-08 | 2021-12-31 | 0001583771-22-000003 | EDGAR | — |
| 2021-03-31 | 2020-12-31 | 0001558370-21-003836 | EDGAR | — |
| 2020-05-14 | 2019-12-31 | 0001104659-20-061587 | EDGAR | — |
| 2019-03-14 | 2018-12-31 | 0001104659-19-014652 | EDGAR | — |
| 2017-09-28 | 2017-06-30 | 0001104659-17-059696 | EDGAR | — |
| 2016-09-28 | 2016-06-30 | 0001104659-16-147194 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-12 | 2025-09-30 | 0001493152-25-021864 | EDGAR | 21K words |
| 2025-08-14 | 2025-06-30 | 0001641172-25-023944 | EDGAR | — |
| 2025-05-19 | 2025-03-31 | 0001641172-25-011534 | EDGAR | — |
| 2024-11-14 | 2024-09-30 | 0001493152-24-046002 | EDGAR | — |
| 2024-08-13 | 2024-06-30 | 0001493152-24-031582 | EDGAR | — |
| 2024-05-21 | 2024-03-31 | 0001628280-24-024560 | EDGAR | — |
| 2023-11-20 | 2023-09-30 | 0001583771-23-000013 | EDGAR | — |
| 2023-08-14 | 2023-06-30 | 0001583771-23-000010 | EDGAR | — |
| 2023-05-12 | 2023-03-31 | 0001583771-23-000007 | EDGAR | — |
| 2022-11-14 | 2022-09-30 | 0001583771-22-000012 | EDGAR | — |
| 2022-08-15 | 2022-06-30 | 0001583771-22-000009 | EDGAR | — |
| 2022-05-16 | 2022-03-31 | 0001583771-22-000006 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-03-18 | 0001493152-26-011222 | EDGAR | 1K words |
| 2026-03-03 | 0001493152-26-008650 | EDGAR | — |
| 2026-01-15 | 0001493152-26-002428 | EDGAR | — |
| 2025-06-30 | 0001641172-25-017037 | EDGAR | — |
| 2025-06-12 | 0001641172-25-014858 | EDGAR | — |
| 2025-06-09 | 0001641172-25-014320 | EDGAR | — |
| 2025-05-30 | 0001641172-25-013048 | EDGAR | — |
| 2025-05-12 | 0001641172-25-009744 | EDGAR | — |
| 2025-05-06 | 0001641172-25-008761 | EDGAR | — |
| 2025-04-17 | 0001641172-25-005241 | EDGAR | — |
359 total filings indexed. 327 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001583771 |
| Ticker | HEPA |
| Exchange | OTC |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Headquarters | Morristown, New Jersey |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report